Title:
NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE, AND COMPOSITION AND PHARMACEUTICAL APPLICATION THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/208165
Kind Code:
A1
Abstract:
The present invention relates to a compound represented by general formula (I) or a stereoisomer, a deuterated product, a solvate, a prodrug, a metabolite, a pharmaceutically acceptable salt, or a co-crystal thereof, an intermediate thereof, and use thereof in AR-related diseases such as cancer. B-L-K (I)
Inventors:
ZHANG CHEN (CN)
LIAO YUTING (CN)
XU JINXIONG (CN)
YU YAN (CN)
TANG PINGMING (CN)
ZOU SIJIA (CN)
CHEN XIAOGANG (CN)
GAO QIU (CN)
CHENG XINFAN (CN)
LI YUPENG (CN)
LI YAO (CN)
YAN PANGKE (CN)
LIAO YUTING (CN)
XU JINXIONG (CN)
YU YAN (CN)
TANG PINGMING (CN)
ZOU SIJIA (CN)
CHEN XIAOGANG (CN)
GAO QIU (CN)
CHENG XINFAN (CN)
LI YUPENG (CN)
LI YAO (CN)
YAN PANGKE (CN)
Application Number:
PCT/CN2023/091444
Publication Date:
November 02, 2023
Filing Date:
April 28, 2023
Export Citation:
Assignee:
SICHUAN HAISCO PHARMACEUTICAL CO LTD (CN)
International Classes:
C07D403/06; A61K31/444; A61K31/496; A61K31/517; A61P35/00; C07D401/14; C07D487/04
Domestic Patent References:
| WO2023016518A1 | 2023-02-16 | |||
| WO2022007903A1 | 2022-01-13 | |||
| WO2021087093A1 | 2021-05-06 | |||
| WO2022017442A1 | 2022-01-27 |
Foreign References:
| CN115160311A | 2022-10-11 | |||
| CN115286617A | 2022-11-04 | |||
| CN111615512A | 2020-09-01 | |||
| CN112010858A | 2020-12-01 |
Attorney, Agent or Firm:
BEIJING SANYOU INTELLECTUAL PROPERTY AGENCY LTD. (CN)
Download PDF: